Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-08-22A RANDOMIZED COMPARATIVE STUDY ASSESSING THE SWITCHING BETWEEN PF-06410293 AND HUMIRA (REGISTERED) IN COMBINATION WITH METHOTREXATE IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS
-
CLINICAL_TRIALS study record update · 2022-08-17Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA).
-
CLINICAL_TRIALS study record update · 2022-08-16Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2022-08-11Effects of Kinesiotaping for Hands Function in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2022-08-11Safety and Effectiveness Study of Ascension PyroCarbon Radial Head Compared to Ascension Metal Radial Head
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-08-11Determination of the Biological Activity of Serum From Patients With Rheumatoid Arthritis After Consumption of Three Different Probiotics Strains (Lactobacillus Salivarius, Rhamnosus, Bifidobacterium Lactis)
-
CLINICAL_TRIALS study record update · 2022-08-03A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Ascending Doses of TJ003234 in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2022-08-03Monıtorıng Glucocortıcoıd Treatment Using Glucocorticoid Toxicity Index (GTI) In Patıents Followed In Rheumatology Clınıc
-
CLINICAL_TRIALS study record update · 2022-07-292-Year Post-Approval Study to Investigate the STAR Ankle Under Actual Conditions of Use
-
CLINICAL_TRIALS study record update · 2022-07-29Pilot Study Investigating a New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2022-07-18A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of GLPG3970, Administered Orally for 6 Weeks in Adult Subjects With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
-
CLINICAL_TRIALS study record update · 2022-07-15Impact of a Pre-operative Rehabilitation Exercise Program for Patients With Severe Dysfunction Awaiting Total Knee Arthroplasty
-
CLINICAL_TRIALS study record update · 2022-07-14Randomized Controlled Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.
-
CLINICAL_TRIALS study record update · 2022-07-13Yoga-mindfulness for Pain Management in Inflammatory Arthritis - a Pragmatic Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-07-12Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
-
CLINICAL_TRIALS study record update · 2022-07-12A Clinical Study to Evaluate the Safety and Efficacy of Microscopic Doses Oral Administration of Gold Nanoparticles (AuNPs) on Knee Joint Health and Function
-
CLINICAL_TRIALS study record update · 2022-07-08A Multicenter, Randomized, Open-label, Blinded-assessor, Phase 4 Study in Patients With Early Rheumatoid Arthritis to Compare Active Conventional Therapy Versus Three Biologic Treatments, and Two De-escalation Strategies in Patients Who Respond to Treatment
-
CLINICAL_TRIALS study record update · 2022-07-08Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis：A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-07-08A Multicenter, Randomized, Open-label, Blinded-assessor, Follow-up, Phase 4 Study in Patients With Rheumatoid Arthritis Who Have Completed the Initial Treatment Part in the NORD-STAR Study and Have Reached Stable Low Disease Activity
-
CLINICAL_TRIALS study record update · 2022-07-07A Prospective, Randomized, Double Blind, Active Controlled Study to Compare PK & Safety of Biosimilar Adalimumab (Advixa) 40 mg/ 0.4 ml of Incepta Pharmaceuticals Ltd. With Humira 40 mg/ 0.4ml of Abbvie Ltd. in Healthy, Adult, Human Subject by Single Subcutaneous Injection Followed by Efficacy & Safety Study in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2022-07-06The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis: A Chart Review Study
-
CLINICAL_TRIALS study record update · 2022-07-05A Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Amorphous Calcium Carbonate in Rheumatoid Arthritis Patients With Osteopenia or Osteoporosis
-
CLINICAL_TRIALS study record update · 2022-06-22Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
-
CLINICAL_TRIALS study record update · 2022-06-22Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints
-
CLINICAL_TRIALS study record update · 2022-06-22YUflyma® (Adalimumab), Patient Experience After Switching to adaliMumab biosimilAr High concenTration, Low Volume (40mg/0.4mL) (Yuflyma®) by Taking Patient pERception of Treatment Into Account: The YU-MATTER Study